- Home
- WHF vs LFCR Comparison
WHF vs LFCR Comparison
Compare WHF & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WHF | LFCR |
|---|---|---|
| Founded | 2011 | 1986 |
| Country | United States | United States |
| Employees | 3 | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.5M | 143.9M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | WHF | LFCR |
|---|---|---|
| Price | $7.63 | $5.06 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $7.75 | $6.00 |
| AVG Volume (30 Days) | 79.4K | ★ 305.7K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 13.67% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.04 |
| P/E Ratio | $15.35 | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $6.07 | $3.63 |
| 52 Week High | $9.68 | $8.98 |
Technical Indicators
Market Signals| Indicator | WHF | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 57.63 | 50.88 |
| Support Level | $6.80 | $3.63 |
| Resistance Level | $7.83 | $5.53 |
| Average True Range (ATR) | 0.14 | 0.29 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 51.43 | 44.58 |
Price Performance
Historical ComparisonAbout WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.